OpenAlex
PricingAboutJobs
Log inGet started
Work

The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts

HTML

Year: 2014
Type: article
Source: Annals of the Rheumatic Diseases
DOI: 10.1136/annrheumdis-2014-205809
Authors: Kerstin Klein, Pawel A Kabala, Aleksander M Grabiec, Renate E Gay, Christoph Kolling, Lih-Ling Lin, Steffen Gay, Paul P Tak, Rab K Prinjha, Caroline Ospelt, Kris A Reedquist
Institutions: University Hospital Zurich, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Schulthess-Klinik, Pfizer (United States), GlaxoSmithKline (United Kingdom), University of Cambridge
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: I-BET151, BET inhibitors, rheumatoid arthritis, synovial fibroblasts, BRD2, BRD3, BRD4, inflammation, matrix metalloproteinases, MMP-1, MMP-3, interleukin-6, interleukin-8, CXCL10, CXCL11, Toll-like receptor ligands, TNF-α, IL-1β, fibroblast proliferation, chemotaxis, epigenetic reader protein, siRNA knockdown
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2122020646
FWCI: 10
Cites: 34
Cited by: 176
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms